Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 465 results found. Search for [ Dr Reddy's Laboratories ]

Results 1 to 21 of 465
PTI
October 29, 2020
On August 11, 2020, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia


BusinessToday.In
October 29, 2020
Dr Reddy's and Russian Direct Investment Fund (RDIF) joined hands to carry out clinical trials and distribute 100 million doses of Sputnik V vaccine across India


BusinessToday.In
October 28, 2020
Dr Reddy's Laboratories share touched an intraday low of Rs 4921.5, down 3.51%


BusinessToday.In
October 28, 2020
Dr Reddy's Laboratories (DRL) on Wednesday posted a 30 per cent fall in net profit to Rs 762.3 crore in the second quarter of FY21 as against Rs 1,092.5 crore in the corresponding period of last year


BusinessToday.In
October 28, 2020
India Stock Market Highlights Today: Global equities were negative today as worries about a surge in coronavirus cases and dwindling hopes for a U.S. stimulus package kept investors gloomy


BusinessToday.In
October 28, 2020
Stocks to watch today on October 28: Hero MotoCorp, Bharti Airtel, Wipro, ICICI Prudential, Tata Motors among others are the top stocks to watch out for in Wednesday's trading session


BusinessToday.In
October 23, 2020
Dr Reddy's Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company


Joe C Mathew
October 22, 2020
On October 22, domestic pharmaceutical major Dr Reddy's Laboratories informed the stock exchanges that the company had been the target of a cyber attack the previous night


BusinessToday.In
October 22, 2020
Feluda, which claims to combine the accuracy of the PCR test with the accessibility of the antigen kits, uses the gene-editing technique CRISPR-Cas9 that had recently earned inventors Emmanuelle Charpentier and Jennifer Doudna the Nobel Prize


BusinessToday.In
October 22, 2020
Dr Reddy's Labs share fell up to 4.24% to Rs 4,832 against previous close of Rs 5046 on BSE


Manoj Sharma
October 22, 2020
Dr Reddy's has partnered with Russian Direct Investment Fund to conduct trials of Sputnik V and distribute vaccine in India; after the cyber attack, its stock is 2.96% or Rs 149.20 down at Rs 4,897.55 compared to previous session's close of Rs 5,046.75


BusinessToday.In
October 22, 2020
India Stock Market Highlights Today: ICICI Bank, followed by Asian Paints, Reliance Industries, PowerGrid, Nestle India and SBI were among the top losers today. On the other hand, Bajaj Finserv, Bajaj Finance, Bharti Airtel, L&T and UltraTech Cement were among the gainers


BusinessToday.In
October 21, 2020
India Stock Market Highlights Today: IndusInd Bank, followed by HDFC, Tata Steel, ICICI Bank, Axis Bank, SBI, Titan, Kotak Bank and Reliance Industries were among the top gainers today. On the other hand, Nestle India, HUL and TCS were among the laggards


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


BusinessToday.In
October 9, 2020
Russian Health Minister Mikhail Murashko had said earlier that he expects to approve a Russian coronavirus vaccine developed by the Vector institute in mid-October


BusinessToday.In
New Delhi, October 9, 2020
India's drug regulator has declined a proposal from Hyderabad-based Dr Reddy's Laboratories Ltd to carry out a large study in the country to evaluate Russia's Sputnik-V coronavirus vaccine. The recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from early-stage studies being conducted overseas is small, with no inputs available on Indian participants. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's asked to resubmit application for conducting trials of Sputnik V


BusinessToday.In
October 8, 2020
Coronavirus vaccine update: The CDSCO panel said that safety and immunogenicity data from early-stage trials of the Russian vaccine Sputnik V that were conducted overseas had a small number of participants


Aarti Raote | Jimish Vakharia | Mayur Deokar
October 7, 2020
Traditionally it has been observed that the Trust route has been subject to misuse and hence there are certain regulatory factors which need to be considered for employeestock award scheme(s)


Aarti Raote | Jimish Vakharia | Reena Poddar | Kejal Punamiya
October 7, 2020
With the COVID-19 pandemic presenting unprecedented business disruption, stock awards could be an effective tool for motivating and retaining key talent while deferring immediate cash outflow


Aprajita Sharma
October 6, 2020
With the construction of MSCI India Domestic & World Healthcare 45 Index Fund for Edelweiss, the MSCI has forayed into the Indian market for the first time


PAGES 1 OF 24  12345